Doximity insider plans sale of 2,000 shares under Rule 144

Doximity insider files notice to sell common stock under Rule 144.

Rhea-AI Filing Summary

Doximity insider files notice to sell common stock under Rule 144. The filing reports a planned sale of 2,000 shares of Doximity common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $101,420.00. These 2,000 shares were acquired on 12/01/2025 via a stock option exercise paid in cash on the same date. Common shares outstanding are listed as 137,373,858.

The filer also discloses prior sales over the past three months: 2,000 common shares on 11/03/2025 for gross proceeds of $132,880.00, 2,000 shares on 10/01/2025 for $140,020.00, and 2,000 shares on 09/02/2025 for $133,140.00. The signer represents that they are not aware of undisclosed material adverse information about Doximity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for DOCS disclose?

The Form 144 discloses a planned sale of 2,000 Doximity common shares on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $101,420.00.

How were the Doximity (DOCS) shares being sold acquired?

The 2,000 Doximity common shares were acquired on 12/01/2025 through a stock option exercise, paid in cash on the same date.

How many Doximity (DOCS) shares are reported as outstanding in this notice?

The notice lists 137,373,858 common shares of Doximity as outstanding.

What prior Doximity (DOCS) stock sales are reported in the last three months?

The filer reports three prior sales of 2,000 Doximity common shares each: on 11/03/2025 for $132,880.00, on 10/01/2025 for $140,020.00, and on 09/02/2025 for $133,140.00 in gross proceeds.

Which broker is handling the planned Doximity (DOCS) share sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY 10004.

What representation does the insider make in this DOCS Form 144?

By signing the notice, the insider represents that they do not know any material adverse information about Doximity’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001862897
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOXIMITY, INC.
SEC File Number	001-40508
Address of Issuer	500 3rd Street Ste 510 San Francisco CALIFORNIA 94107
Phone	650-549-4330
Name of Person for Whose Account the Securities are To Be Sold	KIRA WAMPLER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	101420.00	137373858	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/01/2025	Stock Option Exercise	ISSUER			2000	12/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	11/03/2025	2000	132880.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	10/01/2025	2000	140020.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/02/2025	2000	133140.00

144: Remarks and Signature

Remarks
Date of Notice	12/01/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kira Scherer Wampler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)